Cargando…
Abstract 48: A Clinically Relevant Protocol for Vascularized Composite Allotransplantation Using A Single Dose of AMD3100 for Stem Cell Mobilization
Autores principales: | Swearingen, Bruce J., Graves, Scott S., Storb, Rainer, Mathes, David W. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer Health
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5417901/ http://dx.doi.org/10.1097/01.GOX.0000516568.48468.db |
Ejemplares similares
-
Abstract 40: AMD3100 (Plerixafor) As A Single-Dose Stem Cell Mobilizing Agent In Vascularized Composite Tissue Allograft (VCA) Transplantation In A Canine Model
por: Swearingen, Bruce J., et al.
Publicado: (2018) -
Abstract 47: AMD3100 (Plerixafor) As A Single-Dose Stem Cell Mobilizing Agent In Vascularized Composite Tissue Allograft (VCA) Transplantation In A Canine DLA-Mismatch Model
por: Swearingen, Bruce J., et al.
Publicado: (2019) -
Abstract P14: A Novel Forelimb Orthotopic Allotransplantation Model in Mouse
por: Zhou, Xianyu, et al.
Publicado: (2017) -
Abstract 23: Ultrasound-mediated on-demand release from ionically cross-linked hydrogel: New approach for targeted Immunotherapy in Vascularized Composite Allotransplantation
por: Feturi, Firuz G., et al.
Publicado: (2017) -
Abstract 44: Tolerance Induction with Post Transplantation High-Dose Cyclophosphamide relies on Recipient-derived Immune Regulation and Donor Bone Marrow in a Murine Model of Vascularized Composite Allotransplantation
por: Furtmüller, Georg J., et al.
Publicado: (2017)